Sports cardiologist James O'Keefe, an author of the Heart paper, counters that Dr. Thompson is an exercise addict.
Meanwhile, Dr. O'Keefe's fellow author on the upcoming Heart paper, Carl Lavie, continues racing at speeds slightly above what their editorial recommends.
In April of this year, Harvard researchers published a paper indicating an upped heart risk.
The Tories sent another shadow minister, Crispin Blunt, off to Washington to consult with the Americans, and a February 2010 green paper put cybersecurity at the heart of Conservative election security pledges.
FORBES: Can The UK's Cybersecurity Spending Boost Survive The "Age Of Austerity"?
The planning white paper puts carbon reductions at the heart of the planning process and obliges local councils to plan new buildings to optimise people's ability to walk or cycle to work.
People who suffer from depression symptoms are far more likely to fall ill with heart disease, a major research paper suggests.
The CVD Taskforce paper can be downloaded in the journals Global Heart, Circulation, the European Heart Journal, and the Journal of the American College of Cardiology.
FORBES: International Cardiology Groups Push For Aggressive Public Health Goals
From Drazen's point of view, the change is scientifically unimportant, because the main conclusion of the paper was that Vioxx poses a risk to the heart, not that such a risk takes 18 months to emerge.
Some key figures tackling the global recession found this paper a useful addition to the debate at the heart of which is this key question: is it best to let debt increase in the hope of stimulating economic growth to get out of the slump, or is it better to cut spending and raise taxes aggressively to get public debt under control?
Merck (nyse: MRK - news - people ) pulled Vioxx from the market two weeks ago, but questions about the heart safety of the drug date back years, to an August 2001 paper in The Journal of the American Medical Association.
They enlisted one of their fellows to do a statistical analysis, and published a Sept. 2001 paper in the Journal of the American Medical Association calling for an investigation into potential heart risks caused by Vioxx and Celebrex, a competing drug from Pfizer (nyse: PFE - news - people ).
They are Americans in their heart, in their minds, in every single way but one: on paper.
According to a posting on the Journal's Web site, editors at the world's top medical journal found by examining a computer diskette that relevant data about Vioxx's risk to the heart compared with an older pain drug, naproxen, were deleted two days before the paper was initially submitted to the Journal.
At one point, the paper was going to be published in The Lancet, but Graham says it was delayed due to conflicts with his bosses at the FDA. Graham on Monday morning said that the paper is not in press at this time, and underscored that his estimate of up to 138, 000 heart attacks and strokes has not changed.
That paper, by two top cardiologists, called for a big clinical trial to specifically prove Vioxx was safe for the heart.
When Topol co-authored an influential paper on Vioxx and Celebrex in 2001, he and his colleagues looked at three certain signs of cardiovascular risk: heart attack, stroke and death.
应用推荐